$17B Merck-Sigma Deal Gets EU Nod After Antitrust Fixes
European antitrust regulators on Monday greenlighted German drug company Merck KGaA's $17 billion acquisition of Sigma-Aldrich Corp., after the U.S.-based Sigma agreed to sell off certain assets, including manufacturing assets in...To view the full article, register now.
Already a subscriber? Click here to view full article